Cargando…
Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review
Leptomeningeal disease (LMD) represents a devastating complication of advanced breast cancer (ABC), with survival of <5 months with multimodal treatment. The role of endocrine therapy (ET), due to its favorable toxicity profile and first-line indication in luminal ABC, appears promising in the se...
Autores principales: | Fernandes, Leonor, de Matos, Leonor Vasconcelos, Cardoso, Débora, Saraiva, Marlene, Medeiros-Mirra, Renata, Coelho, Andreia, Miranda, Helena, Martins, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737195/ https://www.ncbi.nlm.nih.gov/pubmed/33078616 http://dx.doi.org/10.2217/cns-2020-0023 |
Ejemplares similares
-
Sweet’s Syndrome Induced by Aromatase Inhibitor in the Treatment of Early Breast Cancer
por: Cardoso, Debora, et al.
Publicado: (2020) -
Leptomeningeal carcinomatosis in gastric cancer: a case report of a rare yet aggressive entity
por: Baleiras, Mafalda Miranda, et al.
Publicado: (2022) -
Recent Advancements of Treatment for Leptomeningeal Carcinomatosis
por: Gwak, Ho-Shin, et al.
Publicado: (2015) -
Leptomeningeal Carcinomatosis with Delayed Ocular Manifestations
por: Czyz, Craig, et al.
Publicado: (2021) -
Leptomeningeal carcinomatosis or ischemic cerebrovascular disease?
por: Eran, Ayelet, et al.
Publicado: (2021)